CPH Group Valuation
Is CPHN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CPHN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CPHN (CHF65.8) is trading below our estimate of fair value (CHF76.9)
Significantly Below Fair Value: CPHN is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CPHN?
Other financial metrics that can be useful for relative valuation.
| What is CPHN's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CHF 394.48m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.5x |
| Enterprise Value/EBITDA | 2.9x |
| PEG Ratio | -0.6x |
Price to Earnings Ratio vs Peers
How does CPHN's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 24.5x | ||
VETN Vetropack Holding | 10.3x | 12.0% | CHF 652.2m |
AFP Aluflexpack | 25x | -37.4% | CHF 253.4m |
GURN Gurit Holding | 34.8x | 35.4% | CHF 259.5m |
2300 Saudi Paper Manufacturing | 27.7x | 16.7% | ر.س2.8b |
CPHN CPH Group | 5x | -9.0% | CHF 394.5m |
Price-To-Earnings vs Peers: CPHN is good value based on its Price-To-Earnings Ratio (5x) compared to the peer average (24.5x).
Price to Earnings Ratio vs Industry
How does CPHN's PE Ratio compare vs other companies in the European Forestry Industry?
Price-To-Earnings vs Industry: CPHN is good value based on its Price-To-Earnings Ratio (5x) compared to the European Forestry industry average (11x).
Price to Earnings Ratio vs Fair Ratio
What is CPHN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 5x |
| Fair PE Ratio | 13.4x |
Price-To-Earnings vs Fair Ratio: CPHN is good value based on its Price-To-Earnings Ratio (5x) compared to the estimated Fair Price-To-Earnings Ratio (13.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 68.60 | CHF 96.65 +40.9% | 5.8% | CHF 104.00 | CHF 90.00 | n/a | 4 |
| Jun ’25 | CHF 90.20 | CHF 96.65 +7.2% | 5.8% | CHF 104.00 | CHF 90.00 | n/a | 4 |
| May ’25 | CHF 86.00 | CHF 96.65 +12.4% | 5.8% | CHF 104.00 | CHF 90.00 | n/a | 4 |
| Apr ’25 | CHF 87.80 | CHF 96.65 +10.1% | 5.8% | CHF 104.00 | CHF 90.00 | n/a | 4 |
| Mar ’25 | CHF 86.80 | CHF 96.65 +11.3% | 5.8% | CHF 104.00 | CHF 90.00 | n/a | 4 |
| Feb ’25 | CHF 90.00 | CHF 97.95 +8.8% | 5.2% | CHF 104.00 | CHF 90.00 | n/a | 4 |
| Jan ’25 | CHF 85.00 | CHF 97.95 +15.2% | 5.2% | CHF 104.00 | CHF 90.00 | n/a | 4 |
| Dec ’24 | CHF 80.00 | CHF 101.95 +27.4% | 3.2% | CHF 106.00 | CHF 97.80 | n/a | 4 |
| Nov ’24 | CHF 81.00 | CHF 101.95 +25.9% | 3.2% | CHF 106.00 | CHF 97.80 | n/a | 4 |
| Oct ’24 | CHF 85.00 | CHF 101.95 +19.9% | 3.2% | CHF 106.00 | CHF 97.80 | n/a | 4 |
| Sep ’24 | CHF 87.00 | CHF 106.95 +22.9% | 7.6% | CHF 120.00 | CHF 97.80 | n/a | 4 |
| Aug ’24 | CHF 87.00 | CHF 106.95 +22.9% | 7.6% | CHF 120.00 | CHF 97.80 | n/a | 4 |
| Jul ’24 | CHF 84.60 | CHF 106.95 +26.4% | 7.6% | CHF 120.00 | CHF 97.80 | n/a | 4 |
| Jun ’24 | CHF 91.40 | CHF 106.95 +17.0% | 7.6% | CHF 120.00 | CHF 97.80 | CHF 90.20 | 4 |
| May ’24 | CHF 89.20 | CHF 106.95 +19.9% | 7.6% | CHF 120.00 | CHF 97.80 | CHF 86.00 | 4 |
| Apr ’24 | CHF 89.00 | CHF 106.95 +20.2% | 7.6% | CHF 120.00 | CHF 97.80 | CHF 87.80 | 4 |
| Mar ’24 | CHF 90.40 | CHF 97.45 +7.8% | 14.5% | CHF 120.00 | CHF 82.00 | CHF 86.80 | 4 |
| Feb ’24 | CHF 86.40 | CHF 90.90 +5.2% | 10.9% | CHF 100.00 | CHF 75.00 | CHF 90.00 | 4 |
| Jan ’24 | CHF 78.00 | CHF 90.90 +16.5% | 10.9% | CHF 100.00 | CHF 75.00 | CHF 85.00 | 4 |
| Dec ’23 | CHF 77.60 | CHF 90.90 +17.1% | 10.9% | CHF 100.00 | CHF 75.00 | CHF 80.00 | 4 |
| Nov ’23 | CHF 71.20 | CHF 89.78 +26.1% | 11.1% | CHF 100.00 | CHF 75.00 | CHF 81.00 | 4 |
| Oct ’23 | CHF 70.40 | CHF 92.78 +31.8% | 6.6% | CHF 100.00 | CHF 86.40 | CHF 85.00 | 4 |
| Sep ’23 | CHF 73.40 | CHF 92.78 +26.4% | 6.6% | CHF 100.00 | CHF 86.40 | CHF 87.00 | 4 |
| Aug ’23 | CHF 73.20 | CHF 92.80 +26.8% | 6.6% | CHF 100.00 | CHF 85.50 | CHF 87.00 | 4 |
| Jul ’23 | CHF 73.00 | CHF 91.45 +25.3% | 6.0% | CHF 100.00 | CHF 85.50 | CHF 84.60 | 4 |
| Jun ’23 | CHF 66.00 | CHF 93.43 +41.6% | 5.3% | CHF 100.00 | CHF 88.00 | CHF 91.40 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.